HuGE Literature Finder
Records
1
-
30
| Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes. Hematology (Amsterdam, Netherlands) 2023 2 28 (1): 2180704. Papadopoulou Vasiliki, Schoumans Jacqueline, Basset Valentin, Solly Françoise, Pasquier Jérôme, Blum Sabine, Spertini Olivi |
| IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons???60 years with myelodysplastic syndromes. Experimental hematology & oncology 2022 Oct 11 (1): 73. Wu Junying, Zhang Yudi, Qin Tiejun, Xu Zefeng, Qu Shiqiang, Pan Lijuan, Li Bing, Jia Yujiao, Li Chengwen, Wang Huijun, Gao Qingyan, Cai Wenyu, Gong Jingye, Zhao Songyang, Li Fuhui, Gale Robert Peter, Xiao Zhiji |
| ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. International journal of hematology 2022 7 116 (5): 659-668. Morita Yasuyoshi, Nannya Yasuhito, Ichikawa Motoshi, Hanamoto Hitoshi, Shibayama Hirohiko, Maeda Yoshinobu, Hata Tomoko, Miyamoto Toshihiro, Kawabata Hiroshi, Takeuchi Kazuto, Tanaka Hiroko, Kishimoto Junji, Miyano Satoru, Matsumura Itaru, Ogawa Seishi, Akashi Koichi, Kanakura Yuzuru, Mitani Kinu |
| Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. American journal of hematology 2022 1 97 (3): 352-372. Patnaik Mrinal M, Tefferi Ayal |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology 2022 11 . Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience. Frontiers in oncology 2022 4 12 795955. Fattizzo Bruno, Levati Giorgia Virginia, Giannotta Juri Alessandro, Cassanello Giulio, Cro Lilla Marcella, Zaninoni Anna, Barbieri Marzia, Croci Giorgio Alberto, Revelli Nicoletta, Barcellini Wil |
| Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes. Cancer 2021 Jun . Kanagal-Shamanna Rashmi, Montalban-Bravo Guillermo, Sasaki Koji, Darbaniyan Faezeh, Jabbour Elias, Bueso-Ramos Carlos, Wei Yue, Chien Kelly, Kadia Tapan, Ravandi Farhad, Borthakur Gautam, Soltysiak Kelly A, Routbort Mark, Patel Keyur, Pierce Sherry, Medeiros L Jeffrey, Kantarjian Hagop M, Garcia-Manero Guiller |
| Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes. Blood advances 2021 2 5 (4): 1017-1028. Hunter Anthony M, Komrokji Rami S, Yun Seongseok, Al Ali Najla, Chan Onyee, Song Jinming, Hussaini Mohammad, Talati Chetasi, Sweet Kendra L, Lancet Jeffrey E, Padron Eric, List Alan F, Sallman David |
| Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
| Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. British journal of haematology 2021 7 194 (4): 708-717. Martín Iván, Villamón Eva, Abellán Rosario, Calasanz Maria José, Irigoyen Aroa, Sanz Guillermo, Such Esperanza, Mora Elvira, Gutiérrez Míriam, Collado Rosa, García-Serra Rocío, Vara Míriam, Blanco Mª Laura, Oiartzabal Itziar, Álvarez Sara, Bernal Teresa, Granada Isabel, Xicoy Blanca, Jerez Andrés, Calabuig Marisa, Diez Rosana, Gil Ángela, Díez-Campelo María, Solano Carlos, Tormo Mar, |
| The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. International journal of laboratory hematology 2021 7 43 (6): 1501-1509. Ibrar Warda, Zhang Weiwei, Cox Jesse Lee, Cushman-Vokoun Allison, Fu Kai, Greiner Timothy C, Yuan |
| [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
| Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. Journal of clinical pathology 2020 3 73 (11): 728-736. Liu Yen-Chun, Illar Gwendolyn M, Bailey Nathanael Gl |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
| Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer science 2019 Dec . Jiang Lingxu, Luo Yingwan, Zhu Shuanghong, Wang Lu, Ma Liya, Zhang Hua, Shen Chuying, Yang Wenli, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes. Leukemia 2019 Feb . Follo Matilde Y, Pellagatti Andrea, Armstrong Richard N, Ratti Stefano, Mongiorgi Sara, De Fanti Sara, Bochicchio Maria Teresa, Russo Domenico, Gobbi Marco, Miglino Maurizio, Parisi Sarah, Martinelli Giovanni, Cavo Michele, Luiselli Donata, McCubrey James A, Suh Pann-Ghill, Manzoli Lucia, Boultwood Jacqueline, Finelli Carlo, Cocco Luc |
| TET2 rs2454206, TET2 rs12498609 and ASXL1 rs3746609 single nucleotide polymorphisms in patients with myelodysplastic syndromes. Blood cells, molecules & diseases 2019 Feb 74 44-50. Hu Jinjun, Xu Jing, Tian Tingting, Xie Juan, Fan Lifang, Zhu Guiyang, Xia Ting, Chen Xi, Tan Yanhong, Chen Xiuhua, Ren Fanggang, Zhang Yaofang, Wang Hongwei, Xu Zhifa |
| Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes. International journal of hematology 2018 Dec 108 (6): 598-606. Shingai Naoki, Harada Yuka, Iizuka Hiroko, Ogata Yosuke, Doki Noriko, Ohashi Kazuteru, Hagihara Masao, Komatsu Norio, Harada Hirono |
| Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis. Hematology (Amsterdam, Netherlands) 2018 May 1-7. Arbab Jafari Pourya, Ayatollahi Hossein, Sadeghi Ramin, Sheikhi Maryam, Asghari Am |
| Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine. Oncotarget 2018 Apr 9 (27): 19342-19355. Cabezón Marta, Bargay Joan, Xicoy Blanca, García Olga, Borrás Josep, Tormo Mar, Marcé Sílvia, Pedro Carme, Valcárcel David, Jiménez Maria-José, Guàrdia Ramón, Palomo Laura, Brunet Salut, Vall-Llovera Ferran, Garcia Antoni, Feliu Evarist, Zamora Lurdes, |
| Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of cancer research and clinical oncology 2018 Mar . Lin Peipei, Luo Yingwan, Zhu Shuanghong, Maggio Dominic, Yang Haiyang, Hu Chao, Wang Jinghan, Zhang Hua, Ren Yanling, Zhou Xinping, Mei Chen, Ma Liya, Xu Weilai, Ye Li, Zhuang Zhengping, Jin Jie, Tong Hongy |
| Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model. American journal of hematology 2018 Feb . Gangat Naseema, Mudireddy Mythri, Lasho Terra L, Finke Christy M, Nicolosi Maura, Szuber Natasha, Patnaik Mrinal M, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
| Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
| [Mutational analysis of RNA splicing machinery genes SF3B1, U2AF1 and SRSF2 in 118 patients with myelodysplastic syndromes and related diseases]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 Mar 38 (3): 192-197. Wang J Y, Ma J, Lin Y N, Wang J, Shen H, Gui F M, Han C, Li Q H, Song Z, Wang X |
| Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis. PloS one 2017 12 (9): e0185053. Zheng Xue, Zhan Zhi, Naren Duolan, Li Jing, Yan Tianyou, Gong Yupi |
| Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations. Oncotarget 2016 Feb . Aslan Derya, Garde Christian, Nygaard Mette Katrine, Helbo Alexandra Søgaard, Dimopoulos Konstantinos, Hansen Jakob Werner, Severinsen Marianne Tang, Treppendahl Marianne Bach, Sjø Lene Dissing, Grønbæk Kirsten, Kristensen Lasse Somm |
| Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations. American journal of hematology 2016 Jan . Hamilton Betty Ky, Visconte Valeria, Jia Xuefei, Tabarroki Ali, Makishima Hideki, Hasrouni Edy, Abounader Donna, Kalaycio Matt, Sekeres Mikkael A, Sobecks Ronald, Duong Liu Hien, Bolwell Brian, Maciejewski Jaroslaw P, Copelan Edward, Tiu Ramon |
| The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts. BMC cancer 2015 15 484. Kang Min-Gu, Kim Hye-Ran, Seo Bo-Young, Lee Jun Hyung, Choi Seok-Yong, Kim Soo-Hyun, Shin Jong-Hee, Suh Soon-Pal, Ahn Jae-Sook, Shin Myung-Ge |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: